Article in Molecules (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.7field-weighted citation impact, top 25% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
1 citing paper in PubMed, 6 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
8 authors at 1 institution in 1 country.
Wei FengSchool of Pharmaceutical Sciences, Hebei TCM Formula Granule Technology Innovation Center& TCM Formula Granule Research Center of Hebei Province University, Hebei University of Chinese Medicine, Shijiazhuang 050091, China. weifeng@hebcm.edu.cn.ORCID 0000-0002-0048-4020
Yuan ZhouSchool of Pharmaceutical Sciences, Hebei TCM Formula Granule Technology Innovation Center& TCM Formula Granule Research Center of Hebei Province University, Hebei University of Chinese Medicine, Shijiazhuang 050091, China. 18832160770@163.com.
Ling-Yu ZhouSchool of Pharmaceutical Sciences, Hebei TCM Formula Granule Technology Innovation Center& TCM Formula Granule Research Center of Hebei Province University, Hebei University of Chinese Medicine, Shijiazhuang 050091, China. zhuangxzz@163.com.
Li-Ying KangSchool of Pharmaceutical Sciences, Hebei TCM Formula Granule Technology Innovation Center& TCM Formula Granule Research Center of Hebei Province University, Hebei University of Chinese Medicine, Shijiazhuang 050091, China. 13171895576@126.com.
Xiang WangSchool of Pharmaceutical Sciences, Hebei TCM Formula Granule Technology Innovation Center& TCM Formula Granule Research Center of Hebei Province University, Hebei University of Chinese Medicine, Shijiazhuang 050091, China. wangxiangdea@126.com.
Bao-Lin LiSchool of Pharmaceutical Sciences, Hebei TCM Formula Granule Technology Innovation Center& TCM Formula Granule Research Center of Hebei Province University, Hebei University of Chinese Medicine, Shijiazhuang 050091, China. libaol2016@163.com.
Qing LiSchool of Pharmaceutical Sciences, Hebei TCM Formula Granule Technology Innovation Center& TCM Formula Granule Research Center of Hebei Province University, Hebei University of Chinese Medicine, Shijiazhuang 050091, China. lqlqlqlqlq5@126.com.
Li-Ying NiuSchool of Pharmaceutical Sciences, Hebei TCM Formula Granule Technology Innovation Center& TCM Formula Granule Research Center of Hebei Province University, Hebei University of Chinese Medicine, Shijiazhuang 050091, China. niuliyingyy@126.com.
Hebei University of Chinese Medicine · CN
Funding
Hebei Provincial Natural Science Foundation of China H2012206019; H2018423065
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Novel Cucurbitane Triterpenes from the Tubers of · full record | OpenQuestion